MILLIMAN BIOKate developed and manages the health outcomes research practice in the NY office and consults to pharmaceutical companies, medical device manufacturers, healthcare industry trade organizations and disease and medical management vendors with a focus on quantifying and communicating the financial value of particular products and services. Many of the projects involve combining epidemiological data, clinical trial outcomes, payer claim data and benefit design to produce metrics for actuarial modeling. Kate also consults to provider groups evaluating and engaging in population risk contracts (ACOs, IDNs etc.) with a focus on benchmarking population claim cost experience and evaluating opportunities for cost reduction. An area of recent work has been analyzing bundled payment contracting for providers.Prior to joining Milliman, she worked for a case-management company, where she developed the company’s case manager training and education program. Kate was previously an instructor in the nursing program at Columbia University School of Nursing. Prior to that, she was a research assistant at Memorial Sloane Kettering, where she was involved in nursing research studies. She also worked as a research assistant in pharmaceutical research studies at Roosevelt Hospital.Kate’s clinical background includes extensive experience as a registered nurse in emergency, adult inpatient, and ambulatory care units.PRESENTATIONS AND PUBLICATIONSIn addition to being a frequent speaker at industry events, Kate is author or coauthor of numerous publicly available white papers and peer review journal publications focused on health cost outcomes research on topics including diabetes, COPD, atrial fibrillation, hepatitis C, oncology, hypertension, hyperlipidemia, contraception, obesity and major depressive disorder. Kate has published several Milliman research reports on the topics of managing population risk as an ACO and bundled payment contracting.